ISIN | CH0586377134 |
---|---|
Valor Number | 58637713 |
Bloomberg Global ID | |
Fund Name | acrevis spektrum Fund Aktien Schweiz VtN |
Fund Provider |
acrevis Bank AG
St. Gallen, Switzerland Phone: +41 58 122 75 55 E-Mail: info@acrevis.ch Web: www.acrevis.ch |
Fund Provider | acrevis Bank AG |
Representative in Switzerland | |
Distributor(s) |
acrevis Bank AG St. Gallen |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Das Anlageziel besteht hauptsächlich darin, einen langfristigen Kapitalzuwachs verbunden mit angemessenen Erträgen zu erzielen und die Performance des im Anhang erwähnten Referenzindex (nachfolgend "Referenzindex") durch aktives Management zu übertreffen, wobei von Anlagen im Referenzindex abgewichen werden kann. |
Peculiarities |
Current Price * | 124.78 CHF | 13.03.2025 |
---|---|---|
Previous Price * | 125.33 CHF | 12.03.2025 |
52 Week High * | 128.76 CHF | 13.02.2025 |
52 Week Low * | 111.47 CHF | 18.04.2024 |
NAV * | 124.78 CHF | 13.03.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 165,144,541 | |
Unit/Share Assets *** | 164,908,930 | |
Trading Information SIX |
YTD Performance | +8.77% |
31.12.2024 - 13.03.2025
31.12.2024 13.03.2025 |
---|---|---|
1 month | -3.09% |
13.02.2025 - 13.03.2025
13.02.2025 13.03.2025 |
3 months | +7.79% |
13.12.2024 - 13.03.2025
13.12.2024 13.03.2025 |
6 months | +4.19% |
13.09.2024 - 13.03.2025
13.09.2024 13.03.2025 |
1 year | +8.06% |
13.03.2024 - 13.03.2025
13.03.2024 13.03.2025 |
2 years | +25.46% |
13.03.2023 - 13.03.2025
13.03.2023 13.03.2025 |
3 years | +17.61% |
14.03.2022 - 13.03.2025
14.03.2022 13.03.2025 |
5 years | +24.78% |
25.01.2021 - 13.03.2025
25.01.2021 13.03.2025 |
Equity Participation Rate in % | 99.80 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 11.71% | |
---|---|---|
Novartis AG Registered Shares | 11.39% | |
Roche Holding AG | 11.09% | |
Compagnie Financiere Richemont SA Class A | 5.66% | |
Lonza Group Ltd | 5.58% | |
ABB Ltd | 5.40% | |
Zurich Insurance Group AG | 5.29% | |
Swiss Life Holding AG | 4.59% | |
Logitech International SA | 4.28% | |
Partners Group Holding AG | 3.42% | |
Last data update | 31.01.2025 |
TER | 0.00% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |